IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BIGGIOGGERO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.830
NA - Nord America 2.630
EU - Europa 2.010
SA - Sud America 313
AF - Africa 83
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.510
SG - Singapore 888
CN - Cina 781
IT - Italia 450
GB - Regno Unito 381
VN - Vietnam 336
HK - Hong Kong 260
RU - Federazione Russa 243
BR - Brasile 235
DE - Germania 210
SE - Svezia 181
BD - Bangladesh 121
FR - Francia 121
FI - Finlandia 90
NL - Olanda 88
IN - India 84
CA - Canada 83
IE - Irlanda 73
JP - Giappone 60
TR - Turchia 60
ID - Indonesia 53
KR - Corea 46
CI - Costa d'Avorio 36
UA - Ucraina 31
AR - Argentina 29
IQ - Iraq 22
ES - Italia 21
BE - Belgio 19
PL - Polonia 18
CO - Colombia 17
MX - Messico 17
PH - Filippine 16
EU - Europa 14
TW - Taiwan 14
ZA - Sudafrica 14
AU - Australia 13
UZ - Uzbekistan 11
AT - Austria 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
IR - Iran 9
EC - Ecuador 8
MA - Marocco 8
MY - Malesia 8
PK - Pakistan 8
SA - Arabia Saudita 8
CL - Cile 7
GR - Grecia 7
LT - Lituania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
DZ - Algeria 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
JO - Giordania 4
KZ - Kazakistan 4
MD - Moldavia 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AP - ???statistics.table.value.countryCode.AP??? 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
AO - Angola 2
BB - Barbados 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
IS - Islanda 1
Totale 7.887
Salva come PNG Salva come JPEG
Città #
Singapore 469
Ashburn 321
Southend 302
Chandler 275
Hong Kong 240
San Jose 176
Dallas 161
Beijing 146
Milan 146
Ho Chi Minh City 116
New York 91
Los Angeles 90
Council Bluffs 89
Santa Clara 86
Princeton 83
Hanoi 80
Seattle 76
Dublin 72
Frankfurt am Main 62
Helsinki 54
Ann Arbor 53
Fairfield 51
Wilmington 49
Lauterbourg 46
Moscow 46
Toronto 45
Dearborn 44
Guangzhou 39
Bengaluru 38
Abidjan 36
Jakarta 35
Tokyo 35
Grafing 34
Rome 31
Munich 30
Buffalo 29
Woodbridge 27
Houston 26
Hefei 25
Cambridge 23
Nanjing 22
Redmond 22
Boardman 21
Haiphong 21
Shanghai 21
Cangzhou 20
Des Moines 20
Da Nang 19
Mountain View 18
São Paulo 17
The Dalles 17
Bologna 16
Phoenix 16
Montreal 15
Brussels 14
Istanbul 14
Jacksonville 14
Sunnyvale 14
Columbus 13
Medford 13
San Diego 13
London 12
Redwood City 12
Shenyang 12
Turku 12
Bogotá 11
Jinan 11
Seoul 11
Warsaw 11
Hebei 10
Naples 10
Sakarya 10
Somerville 10
Tashkent 10
Washington 10
Andover 9
Berlin 9
Izmir 9
Madrid 9
Nuremberg 9
Hangzhou 8
Orem 8
Porto Alegre 8
Serra 8
Catania 7
Changsha 7
Chicago 7
Edinburgh 7
Fortaleza 7
Johannesburg 7
Stockholm 7
Athens 6
Atlanta 6
Eitensheim 6
Fuzhou 6
Jiaxing 6
New Delhi 6
Quanzhou 6
Redondo Beach 6
San Francisco 6
Totale 4.569
Salva come PNG Salva come JPEG
Nome #
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 467
Baricitinib for COVID-19: a suitable treatment? 264
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 255
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic 246
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 231
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 229
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 224
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events 203
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 199
Role of antimalarials in COVID-19 : observational data from a cohort of rheumatic patients 183
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 182
Sex and Management of Rheumatoid Arthritis 170
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection 169
Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort 165
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome 165
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences 158
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors 151
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials 150
Arthritis and infections 150
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 150
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 150
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry 150
Pregnancy outcomes in women exposed to biologic treatment and affected by chronic arthritis 149
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 149
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives 147
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study 146
Type I interferon therapy and its role in autoimmunity 145
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 145
The challenging definition of naïve patient for biological drug use 144
Upadacitinib and filgotinib: The role of JAK1 selective inhibition in the treatment of rheumatoid arthritis 141
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome 140
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis 136
Sarilumab : patient-reported outcomes in rheumatoid arthritis 135
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date 133
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects 132
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 131
Is there really room for anti-rheumatic drugs in the treatment of COVID-19? 128
The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrolment: data from a systematic review and meta-analysis 126
The geoepidemiology of the antiphospholipid antibody syndrome 124
Osteoporosis 124
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry 116
Vitamin D and spondyloarthritis: Review of the literature 113
Standardization of autoantibody testing : a paradigm for serology in rheumatic diseases 108
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience 107
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights 103
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis 101
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab : results from the Italian GISEA registry 96
Comment on : Bisphosphonates and osteonecrosis of the jaw 89
Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupus 87
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 86
Structural integrity versus radiographic progression in rheumatoid arthritis 81
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients : Results from the GISEA register 76
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an "anchor" drug? 56
Ten-Year Drug Survival of Anti-TNF Agents in the Treatment of Inflammatory Arthritides 54
Survival on treatment with second-line biologic therapy: A cohort study comparing cycling and swap strategies 51
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis 4
Totale 8.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 60 12
2021/2022539 25 28 16 9 17 13 36 98 71 54 45 127
2022/2023829 92 102 106 65 99 140 23 40 77 8 52 25
2023/2024520 30 42 24 43 142 38 14 27 12 23 46 79
2024/20251.595 41 146 56 144 149 90 119 153 89 129 154 325
2025/20263.225 299 224 380 288 305 209 587 114 280 209 330 0
Totale 8.214